Modern Multicomponent Reactions for better Drug Syntheses**

Area of Science:

• Organic Chemistry
• Medicinal Chemistry
• Drug Discovery

Background:

• Multicomponent reaction (MCR) technology is recognized for its potential in drug discovery.
• Industry and academia endorse MCRs, yet few MCR-based products are currently marketed.
• A gap exists between MCR potential and market realization, presenting opportunities for innovation.

Purpose of the Study:

• To highlight the significant opportunities for organic chemists presented by MCR technology.
• To emphasize the potential of MCRs in reducing the cost-of-goods for pharmaceutical products.
• To illustrate the practical application of MCRs in shortening synthetic pathways using a relevant drug example.

Main Methods:

• Review of multicomponent reaction (MCR) applications in organic synthesis.
• Analysis of MCR impact on synthetic pathway length and cost-efficiency.
• Case study: Incorporation of MCRs into the synthesis of the Hepatitis C Virus (HCV) drug Telaprevir.

Main Results:

• MCRs enable the shortening of synthetic pathways, leading to considerable cost reductions.
• The synthesis of Telaprevir was significantly improved by introducing two MCR steps.
• The application of MCRs in the Telaprevir synthesis resulted in a reduction of the synthetic route by over 50%.

Conclusions:

• MCR technology offers a powerful strategy for efficient drug synthesis and cost reduction.
• There is substantial untapped potential for MCRs in pharmaceutical development and manufacturing.
• The successful integration of MCRs, exemplified by Telaprevir, validates their utility in shortening complex synthetic routes.